Home
About Us
Information & Guidelines
Article Processing Charges
Open Access Policy
Terms and Conditions
Privacy Policy
Information For Authors
Information Editorial Board
Contact Us
FAQ
Paper Submission Guideline
Register
Login
Submit Now
Vol - 30, Issue - 02
Full-Text PDF
About the Journal
Download
[This article belongs to Volume - 30, Issue - 02]
International Medical Journal
Journal ID
:
IMJ-12-02-2023-1595
Total View
:
406
Title
:
Comparison of Efficacy and Safety Between Ethinyl Estradiol and Dienogest with depot Medroxy Progesterone Acetate in Pelvic Endometriosis
Abstract
: Endometriosis is defined as the presence of endometrium-like tissue (glands and stroma) outside the lining of uterine cavity, which induces a chronic inflammatory reaction, scar tissue, and adhesions that may distort a woman’s pelvic anatomy [1]. The associated symptoms can impact the patient’s general physical, mental, and social well-being. The present study was undertaken to compare efficacy and side effects of Dienogest and ethinyl estradiol combination with Depot Medroxy Progesterone acetate in the treatment of endometriosis. A single centred, institution based study were carried out from March 2020 to February 2021 at the department of Obstetrics and Gynaecology in NRS Medical College and Hospital after obtaining ethical clearance. Among 72 women 15-45 years of age with pelvic endometriosis were included in this study. Study conducted from March 2020 to February 2021. 72 patients were involved in this study. The data was tabulated in Microsoft Excel software and analysed with SPSS V.24 software. The mean age in group 1 is 30.9 and mean age in group 2 is 29.8 years. In group 1, 63.9% had symptoms for 2 to 5 years and in group 2, 44.4 % had symptoms for 2 to 5 years. In group 1, 33.3% patient showed endometrioma in TVS where in group 2, 22.2% patient showed endometrioma in TVS. Treatment was acceptable to 61%patients in group 1 and treatment was acceptable 16.7% patients in group 2. Treatment was more acceptable in dienogest and ethinyl estradiol group. Ethinyl estradiol and Dienogest is a safe and effective drug for off label use in pain management of pelvic endometriosis. However, further studies in larger population with conventional Combined OCP s as control are needed.
Download Info
×
Paper Access Key
Access Key
Submit
No Access Key (
Request for Download
)
Name
Email
Country
Send Request
Our Certificates
Guidelines
Information For Authors
Information Editorial Board
FAQ
Further Information
Article Processing Charges
Open Access Policy
Terms and Conditions
Privacy Policy
//